Jim Simons Diffusion Pharmaceuticals Inc. Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$3.34 - $4.7 $4,008 - $5,640
1,200 Added 3.07%
40,309 $135,000
Q1 2023

May 12, 2023
BUY
$4.15 - $6.6 $1,245 - $1,980
300 Added 0.77%
39,109 $162,000
Q4 2022

Feb 13, 2023
SELL
$4.64 - $6.52 $24,128 - $33,904
-5,200 Reduced 11.82%
38,809 $196,000
Q3 2022

Nov 14, 2022
SELL
$5.35 - $8.38 $25,487 - $39,922
-4,764 Reduced 9.77%
44,009 $235,000
Q2 2022

Aug 12, 2022
BUY
$5.66 - $14.0 $276,055 - $682,822
48,773 New
48,773 $326,000

Others Institutions Holding DFFN

# of Institutions
2
Shares Held
49
Call Options Held
0
Put Options Held
0
View Full List

About Diffusion Pharmaceuticals Inc.

DFFN Quotes by TradingView
  • Ticker DFFN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,039,120
  • Market Cap $18.9M
  • Description
  • Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 a...
More about DFFN
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email